Fig. 6
From: A novel Alzheimer’s disease drug candidate targeting inflammation and fatty acid metabolism
CAD-31 increases the expression of proteins associated with synapses, neurogenesis, and mitochondrial function in hippocampal tissue. a Drebrin. b Arc-1. c Doublecortin (DCX). d Oligomycin sensitivity-conferring protein (OSCP). *** p < 0.001; ** p < 0.01; * p < 0.05. n = 6 per group. C + 31 CAD-31-treated control mice, AD + 31 CAD-31-treated Alzheimer’s disease APPswe/PS1∆E9 mice, MW Molecular weight